CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 2

The Development of Inhaled Products

Today, we have decades of development of inhaled products behind us. This development has led to the availability of very efficient products that have remarkably imp...
Continue Reading →
Volume 16 Issue 2

The Great Why Questions About Dry Powder Inhalers  

The research pertains to the economic burden of asthma and chronic ob- structive pulmonary disease and the impact of poor inhalation techniques with commonly prescri...
Continue Reading →
Volume 16 Issue 2

Emerging Trends in Nasal Spray Development: Tools for Future Success 

A Brief History of Nasal Drug Delivery   Nasal drug delivery has significantly evolved since its inception several decades ago. Initially, it was primarily u...
Continue Reading →
Volume 16 Issue 2

Advances in Intranasal Vaccine Delivery: A Promising Non-Invasive Route of Immunisation  

Vaccination is an effective weapon for disease prevention and has been proven to significantly reduce the transmission of infections and the number of deaths worldwi...
Continue Reading →
Volume 16 Issue 2

Accelerating the Go-To-Market of Nasal Combination Products with Integrated Solutions   

Ear, Nose, Throat Market Trends Outlook  The overall Ear, Nose, and Throat (ENT) market was heavily impacted by Covid-19 pandemic due to masks-wearing, lockd...
Continue Reading →
Volume 16 Issue 1

Harnessing The Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

An Interview with Veranova’s Craig Grant Persistent challenges in poor solubility and low bioavailability have long impeded the pharmaceutical development pipelin...
Continue Reading →
Volume 16 Issue 1

Navigating the 2024 Life Science Landscape: Trends, Challenges, and Opportunities

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. ...
Continue Reading →
Volume 16 Issue 1

Proposed March-in Guidance Signals Funding Agencies to Actively Evaluate Government Rights Under the Bayh-dole Act

The Bayh-Dole Act (“Bayh-Dole”) governs the rights to inventions made with federal assistance. It offers ownership rights to federal award recipients (“Contractors”)...
Continue Reading →
Volume 16 Issue 1

Updating Your Regulatory Information Management Capability? It Could Pay to Get Hands-on

Letting business-savvy techies play around with a new RIM system ahead of the proposed implementation could save Life Sciences companies a fortune, says Romuald Brau...
Continue Reading →
Volume 16 Issue 1

The Delivery of Pharmaceutical Drugs and How it Will Change the Future

Pharmaceutical drugs have seen a seismic shift over the past ten years, moving away from chemically synthesised drugs to focus more on a new class of biological drug...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026